FRANK BEDU-ADDO - 19 Jan 2022 Form 4 Insider Report for PDS Biotechnology Corp (PDSB)

Role
President/CEO, Director
Signature
/s/ Frank Bedu-Addo
Issuer symbol
PDSB
Transactions as of
19 Jan 2022
Net transactions value
$0
Form type
4
Filing time
20 Jan 2022, 15:05:37 UTC
Previous filing
17 Jun 2021
Next filing
02 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PDSB Stock Option (Right to Buy) Award $0 -291,500 -50% $0.000000 291,500 19 Jan 2022 Common Stock 291,500 $6.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, representing a right to purchase a total of 291,500 shares of Common Stock, will become exercisable on January 19, 2023, with 25% vesting on that date and the remaining vesting in equal monthly installments thereafter, subject to continued service to the Issuer through each vesting date, until fully vested on January 19, 2026.